Weight Loss Jab Price Shockwave: Mounjaro Users Face Triple Cost & Scramble for Alternatives

Mounjaro, a popular weight loss drug manufactured by US pharmaceutical giant Lilly, is set to more than double in price for private users in the UK starting September 1. The wholesale cost of a month's supply of the highest dose will surge from £122 to £330. Lilly justified the increase by stating the initial UK launch price was
You may also like...
Zambia Health Crisis: Minister Katakwe Unleashes Shockwave with ZAMMSA Purge

Zambia's Health Minister, Dr. Alex Katakwe, has initiated a major overhaul at the Zambia Medicines and Medical Supplies ...
Political Firestorm: Miles Sampa's Bold Power Grab Rocking Zambia's PF

The Patriotic Front (PF) is navigating a complex leadership crisis following a High Court ruling that validated Miles Sa...
Abuja's Wike-Built Bus Terminal Collapses Under Heavy Rain, Causes Gridlock

A torrential downpour caused significant damage to the recently inaugurated Kugbo Bus Terminal in Abuja, leading to seve...
₦3.3 Trillion Loan Plan Ignites Political Fury: Atiku Aide Slams Tinubu Govt

Nigeria's N3.3 trillion electricity intervention fund sparks controversy, with critics citing political motives while pr...
Serrano Readies for Epic Title Defense Against Hanson at MVPW-03

Most Valuable Promotions is set to host MVPW-03 on May 30 in El Paso, Texas, featuring a blockbuster double main event. ...
Wirtz Ignites Debate: Liverpool's 'Giving Up' Against City Scrutinized by VVD

Liverpool midfielder Florian Wirtz has countered captain Virgil van Dijk's assertion that the team gave up in their rece...
'Dune 3' Tickets Sold Out 9 Months Before Release: Fan Hype Reaches Unprecedented Levels

The 2026 box office is experiencing a strong resurgence, highlighted by the highly anticipated December 18 showdown betw...
Marvel's X-Men Reboot Director Unveils Ambitious Plans and Comic Inspirations

Director Jake Schreier revealed that Marvel's X-Men reboot is drawing inspiration from the classic Chris Claremont era o...





